ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution

July 16, 1982

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

December 5, 1997